Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

Biogen beat Wall Street estimates for third-quarter profit, helped by better-than-expected sales of some of its multiple ...

Chipotle shares tank on disappointing Q3 earnings and lowered guidance for the full year. At least five Wall Street analysts ...

China's promise to delay its newest restrictions on the export of the rare earths that are crucial to many high-tech products ...

LONDON (Reuters) -Novo Nordisk's late bid to hijack Pfizer's takeover of U. obesity biotech Metsera marks an aggressive shift ...

Centene on Wednesday raised its 2025 adjusted profit forecast and said it looks to grow its earnings next year, sending ...

U.S. President Donald Trump's Department of Government Efficiency initiative, or DOGE, has wrapped up work at the Securities ...

Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

Tech shares on Wall Street took a beating on Thursday after some megacap earnings reports, while the dollar and U. bond ...

The U. and China agreed on Thursday to pause tit-for-tat fees on each other's ships that became a major irritant in the ...

Apple's iPhone sales growth decelerated during its summertime quarter, but the company still delivered financial results that ...

Global shares dropped on Thursday and were set for their biggest daily decline in three weeks, weighed down by megacaps ...